Evaluation of inter-fraction heart dose for the patients with esophageal cancer who were treated with definitive chemoradiotherapy.

Evaluation of inter-fraction heart dose for the patients with esophageal cancer who were treated with definitive chemoradiotherapy. - Evaluation of inter-fraction heart dose during chemoradiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047497

Enrollment

Registered

2022-04-18

Start date

2022-04-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower thoracic esophageal cancer

Interventions

Patients receive MRI at pre-treatment and once a week during radiation therapy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1: Patients with lower thoracic esophageal cancer. 2: Patients with T2 - T4 stage.

Exclusion criteria

Exclusion criteria: 1: Patients who does not accept to join this study. 2: Patients who can not receive MRI.

Design outcomes

Primary

Measure	Time frame
The radiation dose of heart calculated by dose volume histogram.	—

Countries

Japan

Contacts

Public ContactNoriyoshi Takahashi

Tohoku University Hospital Radiation Oncology

noriyoshi.08.25@rad.med.tohoku.ac.jp022-717-7312

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026